7Tuschl T. Expanding small RNA interference. Nat Biotechnol,2002, 20:446-448.
8Sasaki Y, Itoh F, Kobayashi T, et al. Increased expression of Tfimbrin gene after DNA damage in CHO cells and inactivation of Tfimbrin by CpG methylation in human colorectal cancer cells. Int J Cancer, 2002, 97:211-216.
9Yu JY, DeRuiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA, 2002, 99:6047-6052.
10Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science,2002, 296:550-553.
3Hara I, Miyake H, Takechi Y, et al. Clinical outcome of conserva- tive therapy for stage T1 , grade 3 transitional cell carcinoma of the bladder [ J ]. lnt J Urol,2013,10 ( 1 ) : 19 - 24.
4Babjuk M, Oosterlinck W, Sylvester R, et al. EAU guidelines on non - muscle - invasive urothelial carcinoma of the bladder, the 2011 update[J]. Actas Urol Esp,2012,36(7) :389 -402.
5Costantini C, Millard F. Update on chemotherapy in the treatment of urothelial carcinoma[ J ]. The Scientific World J, 2011,11 : 1981 - 1994.
6DiLorenzo G, Perdona S, Damiano R, et al. Gemcitabine versus ba- cille Calmette - Gu6rin after initial bacille Calmette - Gurin fail- ure in non - muscle - invasive bladder cancer: a multicenter pro- spective randomized trial[ J ]. Cancer,2010,116 ( 8 ) : 1893 - 1900.
7Karak F, Flechon A. Gemcitabine in bladder cancer [ J ]. Expert Opin Pharmacother,2007 ,8 :3251 - 3256.
8Lamm DL, McGee WR, Hale K. et al. Bladder cancer:current op-timal intravesical treatment [ J ]. Urol Nurs, 2011 , 25 ( 5 ) : 323 - 326,331 - 332.
